Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 225 NOK -2.17% Market Closed
Market Cap: kr4.1B

Medistim ASA
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Medistim ASA
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Medistim ASA
OSE:MEDI
Income from Continuing Operations
kr159.2m
CAGR 3-Years
12%
CAGR 5-Years
18%
CAGR 10-Years
15%
Lifecare AS
OSE:LIFE
Income from Continuing Operations
-kr120.2m
CAGR 3-Years
-90%
CAGR 5-Years
-115%
CAGR 10-Years
N/A
O
Observe Medical ASA
OSE:OBSRV
Income from Continuing Operations
-kr48.6m
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
No Stocks Found

Medistim ASA
Glance View

Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

MEDI Intrinsic Value
186.46 NOK
Overvaluation 17%
Intrinsic Value
Price kr225

See Also

What is Medistim ASA's Income from Continuing Operations?
Income from Continuing Operations
159.2m NOK

Based on the financial report for Dec 31, 2025, Medistim ASA's Income from Continuing Operations amounts to 159.2m NOK.

What is Medistim ASA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
15%

Over the last year, the Income from Continuing Operations growth was 53%. The average annual Income from Continuing Operations growth rates for Medistim ASA have been 12% over the past three years , 18% over the past five years , and 15% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett